Bariatric-Metabolic Surgery Utilisation in Patients With and Without Diabetes: Data from the IFSO Global Registry 2015-2018.
Bariatric surgery
Comorbidity
Demographic classification
IFSO Global Registry
Metabolic surgery
Obesity surgery
Operation choice for diabetes
Sex characteristics
Type 2 diabetes
Journal
Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
received:
22
10
2020
accepted:
09
02
2021
revised:
03
02
2021
pubmed:
28
2
2021
medline:
21
5
2021
entrez:
27
2
2021
Statut:
ppublish
Résumé
Comparative international practice of patients undergoing bariatric-metabolic surgery for type 2 diabetes mellitus (T2DM) is unknown. We aimed to ascertain baseline age, sex, body mass index (BMI) and types of operations performed for patients with T2DM submitted to the IFSO Global Registry. Cross-sectional analysis of patients having primary surgery in 2015-2018 for countries with ≥90% T2DM data completion and ≥ 1000 submitted records. Fifteen countries including 11 national registries met the inclusion criteria. The rate of T2DM was 24.2% (99,537 of 411,581 patients, country range 12.0-55.1%) and 77.1% of all patients were women. In every country, patients with T2DM were older than those without T2DM (overall mean age 49.2 [SD 11.4] years vs 41.8 [11.9] years, all p < 0.001). Men were more likely to have T2DM than women, odds ratio (OR) 1.68 (95% CI 1.65-1.71), p < 0.001. Men showed higher rates of T2DM for BMI <35 kg/m Patients with T2DM had different characteristics to those without T2DM. Older men were more likely to have T2DM, with higher rates of BMI <35 kg/m
Sections du résumé
BACKGROUND
Comparative international practice of patients undergoing bariatric-metabolic surgery for type 2 diabetes mellitus (T2DM) is unknown. We aimed to ascertain baseline age, sex, body mass index (BMI) and types of operations performed for patients with T2DM submitted to the IFSO Global Registry.
MATERIALS AND METHODS
Cross-sectional analysis of patients having primary surgery in 2015-2018 for countries with ≥90% T2DM data completion and ≥ 1000 submitted records.
RESULTS
Fifteen countries including 11 national registries met the inclusion criteria. The rate of T2DM was 24.2% (99,537 of 411,581 patients, country range 12.0-55.1%) and 77.1% of all patients were women. In every country, patients with T2DM were older than those without T2DM (overall mean age 49.2 [SD 11.4] years vs 41.8 [11.9] years, all p < 0.001). Men were more likely to have T2DM than women, odds ratio (OR) 1.68 (95% CI 1.65-1.71), p < 0.001. Men showed higher rates of T2DM for BMI <35 kg/m
CONCLUSION
Patients with T2DM had different characteristics to those without T2DM. Older men were more likely to have T2DM, with higher rates of BMI <35 kg/m
Identifiants
pubmed: 33638756
doi: 10.1007/s11695-021-05280-6
pii: 10.1007/s11695-021-05280-6
pmc: PMC8113173
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2391-2400Commentaires et corrections
Type : CommentIn
Références
BMJ. 2014 Nov 27;349:g6608
pubmed: 25430558
Obes Surg. 2015 Oct;25(10):1822-32
pubmed: 25835983
N Engl J Med. 2015 Jul 2;373(1):11-22
pubmed: 26132939
Surg Obes Relat Dis. 2016 Jul;12(6):1171-7
pubmed: 26948939
BMJ. 2016 May 11;353:i1472
pubmed: 27169605
Diabetes Care. 2016 Jun;39(6):861-77
pubmed: 27222544
Obes Surg. 2004 Oct;14(9):1157-64
pubmed: 15527627
Lancet. 2014 Aug 30;384(9945):766-81
pubmed: 24880830
JAMA. 2018 Jan 16;319(3):241-254
pubmed: 29340676
Surg Obes Relat Dis. 2018 May;14(5):545-551
pubmed: 29551470
N Engl J Med. 2016 Jul 28;375(4):311-22
pubmed: 27295427
Obes Surg. 2018 May;28(5):1188-1206
pubmed: 29600339
Health Technol Assess. 2018 Nov;22(68):1-246
pubmed: 30511918
Oncotarget. 2016 Jun 28;7(26):39216-39230
pubmed: 27233078
Surg Obes Relat Dis. 2010 Jan-Feb;6(1):8-15
pubmed: 19782647
JAMA. 2018 Jan 16;319(3):255-265
pubmed: 29340679
Obes Surg. 2013 Apr;23(4):427-36
pubmed: 23338049
Surg Obes Relat Dis. 2018 Mar;14(3):264-269
pubmed: 29519658
Obes Rev. 2018 Jan;19(1):14-27
pubmed: 29024367
Obes Rev. 2020 Jan;21(1):e12932
pubmed: 31733033
Lancet Diabetes Endocrinol. 2019 Dec;7(12):912-924
pubmed: 31678062
Obes Surg. 2018 Feb;28(2):313-322
pubmed: 28822052
Obes Surg. 2019 Mar;29(3):782-795
pubmed: 30421326
Ann Intern Med. 2018 Dec 4;169(11):741-750
pubmed: 30383139
Obes Surg. 2018 Dec;28(12):3916-3922
pubmed: 30027332
Diabet Med. 2011 Jun;28(6):628-42
pubmed: 21480973
Obes Rev. 2020 Jun;21(6):e13011
pubmed: 32162437
N Engl J Med. 2012 Apr 26;366(17):1567-76
pubmed: 22449319
Obes Surg. 2018 Dec;28(12):3783-3794
pubmed: 30121858
Obes Surg. 2018 Sep;28(9):2661-2669
pubmed: 29627947
Ann Surg. 2014 Jan;259(1):117-22
pubmed: 23314274
Obes Surg. 2009 Dec;19(12):1605-11
pubmed: 19885707